Synthesis and evaluation of insulin-human serum albumin conjugates. 2005

Karen Thibaudeau, and Roger Léger, and Xicai Huang, and Martin Robitaille, and Omar Quraishi, and Chantal Soucy, and Nathalie Bousquet-Gagnon, and Pieter van Wyk, and Véronique Paradis, and Jean-Paul Castaigne, and Dominique Bridon
ConjuChem Inc., 225 President-Kennedy Avenue, Montreal, QC, H2X 3Y8 Canada.

A series of human insulin maleimido derivatives with short and long linkers was synthesized by exploiting the variations in the pK(a) values and environment of the three amino groups present in the protein. The syntheses were accomplished in organic solvent because of maleimide's instability in basic aqueous media. The derivatives thus obtained were conjugated to the free thiol on Cys34 of human serum albumin (HSA) and purified. A structure-activity relationship based on in vitro receptor binding and activation results for this series of insulin-HSA conjugates showed that the best compounds were attached at the B1 position of insulin with either short or long linkers. Two conjugates were administered subcutaneously to streptozotocin-induced diabetic rats and found to possess blood glucose normalizing activity up to 8 h post-administration. The return to diabetic plasma glucose levels was not observed within the time frame of the experiment (48 h). In comparison, the insulin-treated group's normalization activity lasted 2 h and returned to a diabetic level at 8 h. The onset of the conjugate activities were delayed by 1 h when compared to the activity of human insulin. The study results led to the identification of CJC-1575 as a potent and long lasting human insulin analogue.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

Karen Thibaudeau, and Roger Léger, and Xicai Huang, and Martin Robitaille, and Omar Quraishi, and Chantal Soucy, and Nathalie Bousquet-Gagnon, and Pieter van Wyk, and Véronique Paradis, and Jean-Paul Castaigne, and Dominique Bridon
December 2020, Pharmaceuticals (Basel, Switzerland),
Karen Thibaudeau, and Roger Léger, and Xicai Huang, and Martin Robitaille, and Omar Quraishi, and Chantal Soucy, and Nathalie Bousquet-Gagnon, and Pieter van Wyk, and Véronique Paradis, and Jean-Paul Castaigne, and Dominique Bridon
January 1994, Bioconjugate chemistry,
Karen Thibaudeau, and Roger Léger, and Xicai Huang, and Martin Robitaille, and Omar Quraishi, and Chantal Soucy, and Nathalie Bousquet-Gagnon, and Pieter van Wyk, and Véronique Paradis, and Jean-Paul Castaigne, and Dominique Bridon
January 2003, Biomeditsinskaia khimiia,
Karen Thibaudeau, and Roger Léger, and Xicai Huang, and Martin Robitaille, and Omar Quraishi, and Chantal Soucy, and Nathalie Bousquet-Gagnon, and Pieter van Wyk, and Véronique Paradis, and Jean-Paul Castaigne, and Dominique Bridon
January 1986, International archives of allergy and applied immunology,
Karen Thibaudeau, and Roger Léger, and Xicai Huang, and Martin Robitaille, and Omar Quraishi, and Chantal Soucy, and Nathalie Bousquet-Gagnon, and Pieter van Wyk, and Véronique Paradis, and Jean-Paul Castaigne, and Dominique Bridon
January 2019, Biomedical engineering online,
Karen Thibaudeau, and Roger Léger, and Xicai Huang, and Martin Robitaille, and Omar Quraishi, and Chantal Soucy, and Nathalie Bousquet-Gagnon, and Pieter van Wyk, and Véronique Paradis, and Jean-Paul Castaigne, and Dominique Bridon
August 2007, Organic & biomolecular chemistry,
Karen Thibaudeau, and Roger Léger, and Xicai Huang, and Martin Robitaille, and Omar Quraishi, and Chantal Soucy, and Nathalie Bousquet-Gagnon, and Pieter van Wyk, and Véronique Paradis, and Jean-Paul Castaigne, and Dominique Bridon
January 1988, The Journal of nuclear medicine and allied sciences,
Karen Thibaudeau, and Roger Léger, and Xicai Huang, and Martin Robitaille, and Omar Quraishi, and Chantal Soucy, and Nathalie Bousquet-Gagnon, and Pieter van Wyk, and Véronique Paradis, and Jean-Paul Castaigne, and Dominique Bridon
January 2004, Bioorganicheskaia khimiia,
Karen Thibaudeau, and Roger Léger, and Xicai Huang, and Martin Robitaille, and Omar Quraishi, and Chantal Soucy, and Nathalie Bousquet-Gagnon, and Pieter van Wyk, and Véronique Paradis, and Jean-Paul Castaigne, and Dominique Bridon
September 1986, Die Pharmazie,
Karen Thibaudeau, and Roger Léger, and Xicai Huang, and Martin Robitaille, and Omar Quraishi, and Chantal Soucy, and Nathalie Bousquet-Gagnon, and Pieter van Wyk, and Véronique Paradis, and Jean-Paul Castaigne, and Dominique Bridon
January 2009, Molecular imaging,
Copied contents to your clipboard!